The global transfection reagents market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for transfection reagents in biomedical research and protein production applications. The increasing number of clinical trials and rising prevalence of chronic diseases are driving the demand for therapeutic delivery applications, which in turn is driving the growth of this market.
The global transfection reagents market by type includes lipid transfection reagent and noliposomeric polymers. The lipid transfection reagent segment accounted for a share of over 60% in 2017, owing to its wide range of applications such as gene therapy, protein production, and therapeutic delivery. Noliposomeric polymers are expected to witness significant growth during the forecast period owing to their ability to deliver nucleic acids into cells without any damage or toxicity effects on cells or tissues.
The global transfection reagents market by application includes biomedical research, protein production, and therapeutic delivery segments. Biomedical research accounted for a share over 50% in 2017 due to its wide range of applications such as gene therapy, protein production, and therapeutic delivery among others; it is also expected that this segment will continue dominating during the forecast period owing to its high adoption rate across various industries including pharmaceuticals & biotechnology companies as well as academic institutions worldwide.
Some Of The Growth Factors Of This Market:
- The increasing number of research and development activities in the field of biotechnology is one of the major factors driving the growth of transfection reagents market.
- The increasing demand for transfection reagents from pharmaceutical and biotechnology companies is another factor driving the growth of this market.
- The growing awareness about gene therapy among people is also a factor that will drive the growth of this market in future years.
- Increasing government funding for research and development activities related to gene therapy is also a factor that will drive the growth of this market in future years.
- Increasing number of clinical trials related to gene therapy are also a factor that will drive the growth of this market in future years.
Industry Growth Insights published a new data on “Transfection Reagents Market”. The research report is titled “Transfection Reagents Market research by Types (Lipid Transfection Reagent, Non-liposomeric Polymers), By Applications (Biomedical Research, Protein Production, Therapeutic Delivery), By Players/Companies Thermo Fisher, Promega, Roche, Qiagen, Polyplus-transfection SA, Bio-Rad Laboratories, Lonza Group, Sigma, Mirus Bio LLC, Maxcyte Inc., Navtech, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Transfection Reagents Market Research Report
By Type
Lipid Transfection Reagent, Non-liposomeric Polymers
By Application
Biomedical Research, Protein Production, Therapeutic Delivery
By Companies
Thermo Fisher, Promega, Roche, Qiagen, Polyplus-transfection SA, Bio-Rad Laboratories, Lonza Group, Sigma, Mirus Bio LLC, Maxcyte Inc., Navtech, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Transfection Reagents Market Report Segments:
The global Transfection Reagents market is segmented on the basis of:
Types
Lipid Transfection Reagent, Non-liposomeric Polymers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biomedical Research, Protein Production, Therapeutic Delivery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher
- Promega
- Roche
- Qiagen
- Polyplus-transfection SA
- Bio-Rad Laboratories
- Lonza Group
- Sigma
- Mirus Bio LLC
- Maxcyte Inc.
- Navtech, Inc.
Highlights of The Transfection Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Lipid Transfection Reagent
- Non-liposomeric Polymers
- By Application:
- Biomedical Research
- Protein Production
- Therapeutic Delivery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transfection Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transfection reagents are chemicals that help to transfer genetic material from one organism to another. They can be used in a variety of ways, including in vitro fertilization (IVF), gene therapy, and cancer treatment.
Some of the key players operating in the transfection reagents market are Thermo Fisher, Promega, Roche, Qiagen, Polyplus-transfection SA, Bio-Rad Laboratories, Lonza Group, Sigma, Mirus Bio LLC, Maxcyte Inc., Navtech, Inc..
The transfection reagents market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Transfection Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Transfection Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Transfection Reagents Market - Supply Chain
4.5. Global Transfection Reagents Market Forecast
4.5.1. Transfection Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Transfection Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Transfection Reagents Market Absolute $ Opportunity
5. Global Transfection Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Transfection Reagents Market Size and Volume Forecast by Type
5.3.1. Lipid Transfection Reagent
5.3.2. Non-liposomeric Polymers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Transfection Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Transfection Reagents Market Size and Volume Forecast by Application
6.3.1. Biomedical Research
6.3.2. Protein Production
6.3.3. Therapeutic Delivery
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Transfection Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Transfection Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Transfection Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Transfection Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Transfection Reagents Demand Share Forecast, 2019-2026
9. North America Transfection Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Transfection Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Transfection Reagents Market Size and Volume Forecast by Application
9.4.1. Biomedical Research
9.4.2. Protein Production
9.4.3. Therapeutic Delivery
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Transfection Reagents Market Size and Volume Forecast by Type
9.7.1. Lipid Transfection Reagent
9.7.2. Non-liposomeric Polymers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Transfection Reagents Demand Share Forecast, 2019-2026
10. Latin America Transfection Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Transfection Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Transfection Reagents Market Size and Volume Forecast by Application
10.4.1. Biomedical Research
10.4.2. Protein Production
10.4.3. Therapeutic Delivery
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Transfection Reagents Market Size and Volume Forecast by Type
10.7.1. Lipid Transfection Reagent
10.7.2. Non-liposomeric Polymers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Transfection Reagents Demand Share Forecast, 2019-2026
11. Europe Transfection Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Transfection Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Transfection Reagents Market Size and Volume Forecast by Application
11.4.1. Biomedical Research
11.4.2. Protein Production
11.4.3. Therapeutic Delivery
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Transfection Reagents Market Size and Volume Forecast by Type
11.7.1. Lipid Transfection Reagent
11.7.2. Non-liposomeric Polymers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Transfection Reagents Demand Share, 2019-2026
12. Asia Pacific Transfection Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Transfection Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Transfection Reagents Market Size and Volume Forecast by Application
12.4.1. Biomedical Research
12.4.2. Protein Production
12.4.3. Therapeutic Delivery
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Transfection Reagents Market Size and Volume Forecast by Type
12.7.1. Lipid Transfection Reagent
12.7.2. Non-liposomeric Polymers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Transfection Reagents Demand Share, 2019-2026
13. Middle East & Africa Transfection Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Transfection Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Transfection Reagents Market Size and Volume Forecast by Application
13.4.1. Biomedical Research
13.4.2. Protein Production
13.4.3. Therapeutic Delivery
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Transfection Reagents Market Size and Volume Forecast by Type
13.7.1. Lipid Transfection Reagent
13.7.2. Non-liposomeric Polymers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Transfection Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Transfection Reagents Market: Market Share Analysis
14.2. Transfection Reagents Distributors and Customers
14.3. Transfection Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Promega
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Roche
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qiagen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Polyplus-transfection SA
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lonza Group
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sigma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Mirus Bio LLC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Maxcyte Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Navtech, Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
